Home | Publications | Treatments | Skin care place holder
place holder place holder

Skin care


Medicated Skin Care in Chile


Publication Date   December 2007
Publisher   Euromonitor International
Product Type   Report
Pages   26
ISBN Number   not applicable
Product Code   EUR830
Ask a question about this product?

Price £450.00

approximately: $795 | €571

Summary


Euromonitor International's Medicated Skin Care in Chile report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

  • Get a detailed picture of the medicated skin care industry
  • Identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


OTC Healthcare - Italy

OTC Healthcare in Italy : Market Insight

EXECUTIVE SUMMARY
Modest growth in 2006 Self-medication ever more important Best performer Whitehall Italia gains second position in 2006 Supermarkets to challenge pharmacy monopoly Modest growth expected despite wider availability KEY TRENDS AND DEVELOPMENTS
OTC Products on Supermarkets'' Shelves Greying Population Wellness Trend Affects OTC Medicines The Importance of Health in Modern Lifestyles Targeting Specific Segments MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Table 11 Number of Prescriptions Issued 2003-2006
De-listing Or De-reimbursement Advertising Packaging and waste Labelling Distribution Vitamins and Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 12 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources

Local Company Profiles - Italy

A Menarini Industrie Farmaceutiche Riunite Srl - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 2 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2006
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 5 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts
Summary 6 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 7 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2006
Bracco SpA - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 9 Bracco SpA: Key Facts
Summary 10 Bracco SpA: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 11 Bracco SpA: Competitive Position 2006
Chiesi Farmaceutici SpA - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 12 Chiesi Farmaceutici SpA: Key Facts
Summary 13 Chiesi Farmaceutici SpA: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 14 Chiesi Farmaceutici SpA: Competitive Position 2006
Perfetti Van Melle SpA - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 15 Perfetti Van Melle SpA: Key Facts
Summary 16 Perfetti Van Melle SpA: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 17 Perfetti Van Melle SpA: Competitive Position 2006
Recordati Industria Chimica e Farmaceutica SpA - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 18 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
Summary 19 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 20 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 21 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2006
Sanofi-Aventis SpA - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 22 Sanofi-Aventis SpA: Key Facts
Summary 23 Sanofi-Aventis SpA: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 24 Sanofi-Aventis SpA: Competitive Position 2006
Sigma-Tau Industrie Farmaceutiche Riunite SpA - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 25 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Key Facts
Summary 26 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 27 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2006
Zambon Italia SpA - OTC Healthcare - Italy
STRATEGIC DIRECTION KEY FACTS
Summary 28 Zambon Italia SpA: Key Facts
Summary 29 Zambon Italia SpA: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 30 Zambon Italia SpA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 31 Zambon Italia SpA: Competitive Position 2006

Analgesics in Italy

HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 13 Sales of Analgesics by Subsector: Value 2001-2006
Table 14 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 15 Herbal vs Standard Topical Analgesics 2001/2006
Table 16 Analgesics Company Shares by Retail Value 2002-2006
Table 17 Analgesics Brand Shares by Retail Value 2003-2006
Table 18 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011